Welcome to LookChem.com Sign In|Join Free
  • or
Oxymorphazone, a semi-synthetic opioid analgesic derived from morphine, is a potent μ-opioid receptor agonist. It is known for its potentially strong analgesic effects, making it a valuable asset for pain relief. While its potential use in treating opioid addiction and dependence is under research due to its ability to activate opioid receptors without inducing the same level of euphoria and physical dependence as other opioids, it also carries a risk of abuse and dependence, necessitating careful monitoring and regulation.

73697-35-5

Post Buying Request

73697-35-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

73697-35-5 Usage

Uses

Used in Pain Management:
Oxymorphazone is used as a potent analgesic for the management of severe pain. Its strong affinity for the μ-opioid receptors makes it effective in providing relief for various types of pain, including postoperative and chronic pain conditions.
Used in Opioid Addiction Research:
Oxymorphazone is being investigated as a potential medication for treating opioid addiction and dependence. It is used as a research compound to explore its ability to activate opioid receptors without producing the same level of euphoria and physical dependence associated with other opioids, offering a possible alternative for managing opioid use disorders.

Check Digit Verification of cas no

The CAS Registry Mumber 73697-35-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,3,6,9 and 7 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 73697-35:
(7*7)+(6*3)+(5*6)+(4*9)+(3*7)+(2*3)+(1*5)=165
165 % 10 = 5
So 73697-35-5 is a valid CAS Registry Number.
InChI:InChI=1/C17H21N3O3/c1-20-7-6-16-13-9-2-3-11(21)14(13)23-15(16)10(19-18)4-5-17(16,22)12(20)8-9/h2-3,12,15,21-22H,4-8,18H2,1H3/b19-10+/t12-,15+,16+,17-/m1/s1

73697-35-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name (4R,4aS,7E,7aR,12bS)-7-hydrazinylidene-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol

1.2 Other means of identification

Product number -
Other names Morphinan-6-one,4,5-epoxy-3,14-dihydroxy-17-methyl-,hydrazone,(5alpha)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:73697-35-5 SDS

73697-35-5Upstream product

73697-35-5Downstream Products

73697-35-5Relevant academic research and scientific papers

Long-Acting Opiate Agonists and Antagonists: 14-Hydroxydihydromorphinone Hydrazones

Pasternak, Gavril W.,Hahn, Elliot F.

, p. 674 - 676 (2007/10/02)

Two new long-acting hydrazone derivatives of 14-hydroxydihydromorphinones have been synthesized, oxymorphazone and naltrexazone.Both derivatives show high affinity for opiate binding sites in vitro, similar to naloxazone, the hydrazone analogue of naloxone.Sodium and manganese shifts imply that naltrexazone, like naloxazone, is a pure antagonist.By contrast, oxymorphazone inhibition of receptor binding is dramatically reduced by sodium and potentiated by manganese, suggesting it is an agonist.When given in vivo, all agents produce a significant inhibition of receptor binding for over 24 h despite extensive washing of the brain homogenates.Oxymorphone, naltrexone, and naloxone are without effect.Twenty-four hours after in vivo administration of oxymorphazone, 82percent of mice are still analgetic compared to only 17percent of oxymorphone-treated mice (p 0.005).Twenty-four hours after naltrexazone or naloxazone treatment all mice were protected from morphine analgesia (12 mg/kg; p 0.005), while naltrexone- and naloxone-treated animals did not differ significantly from saline-treated controls.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 73697-35-5